Stocks · News reference
Bausch Health has authorized a new share repurchase program to buy back up to $50 million of its common shares to offset potential dilution from employee equity compensation.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Bausch Health reported strong third-quarter 2026 financial results, including a 10% increase in consolidated revenues and an increase in adjusted earnings per share, leading the company to raise its financial guidance.
Bausch Health plans to redeem approximately $643 million of its outstanding 8.500% senior notes due in 2027 using cash on hand.
Filed: 2026-10-28 AccNo: 0000885590-26-000121 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits